Monday - February 9, 2026
Experimental pill dramatically reduces 'bad' cholesterol
February 04, 2026
DALLAS, Texas, Feb. 4 -- The University of Texas Southwestern Medical Center posted the following news release:

* * *

Experimental pill dramatically reduces 'bad' cholesterol

*

DALLAS - Feb. 04, 2026 - An experimental pill called enlicitide slashed levels of low-density lipoprotein (LDL) cholesterol, commonly known as "bad" cholesterol, by up to 60%, a new phase three clinical trial published in The New England Journal of Me . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products